CGON R&D to Revenue
Cg Oncology Inc · R&D to Revenue
CGON R&D to Revenue
Latest reported4724.03%period ending
CGON Quarterly R&D/Revenue (0.00% → 4724.03%)
Latest values, visible window
High-resolution chart · PNG
CGON r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 4,724.0277% | |
| 4,037.8578% | |
| 1,290.2239% | |
| 1,673.7095% | |
| 0% | |
| 52,821.1538% | |
| 5,877.193% | |
| 45,632.5581% | |
| 16,639.6396% | |
| 3,253.3081% | |
| 1,591,500% | |
| 130,388.8889% | |
| 0% | |
| 4,042.268% | |
| 0% |